PAA 2.50% 20.5¢ pharmaust limited

PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-840

  1. 2,646 Posts.
    lightbulb Created with Sketch. 1566
    For me, the biggest potential driver of the sp will probably be ignored. And that's the possibility of a partnership or complete takeover, our Business Development Officer has been on the books [it was unheralded at the time] for close to 5 months helping get the word out, and putting Pharmaust in front of the people who count. Additionally the CEO is making no secret Pharmaust is looking for a partner add to that the SAB members are all very well connected to academia and industry along with [Hopefully] ongoing good news regarding the OLE, Pharmaust is putting itself out there.

    It may take until the end of the year or 2025, and that wont bother me in the lest. But it could also happen next month.

    Time will tell.

    Enjoy the weekend.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.